Investigational Drug Information for Velneperit
✉ Email this page to a colleague
What is the development status for investigational drug Velneperit?
Velneperit is an investigational drug.
There have been 4 clinical trials for Velneperit.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Obesity and [disabled in preview]. The leading clinical trial sponsors are Shionogi and [disabled in preview].
Summary for Velneperit
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 203 |
| WIPO Patent Applications | 143 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 2 (2007-06-01) |
| Vendors | 44 |
Recent Clinical Trials for Velneperit
| Title | Sponsor | Phase |
|---|---|---|
| Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects | Shionogi | Phase 2 |
| Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects | Shionogi | Phase 2 |
| Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet | Shionogi | Phase 2 |
Clinical Trial Summary for Velneperit
Top disease conditions for Velneperit
Top clinical trial sponsors for Velneperit
US Patents for Velneperit
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
